These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8273131)

  • 1. The changing activities of a regional marrow donor program.
    Stroncek D; Strand R; Hofkes C; McCullough J
    Transfusion; 1994 Jan; 34(1):58-62. PubMed ID: 8273131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and operation of a program to obtain volunteer bone marrow donors unrelated to the patient.
    McCullough J; Rogers G; Dahl R; Therkelsen D; Kamstra L; Crisham P; Kline W; Bowman R; Scott E; Halagan N
    Transfusion; 1986; 26(4):315-23. PubMed ID: 3523871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of potential marrow donors recruited from apheresis donors or whole blood donors and through appeals to the general public.
    Stroncek DF; Strand RD; Hofkes CL; McCullough J
    Transfusion; 1991 Feb; 31(2):138-41. PubMed ID: 1825362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Marrow Donor Program.
    Stroncek D; Bartsch G; Perkins HA; Randall BL; Hansen JA; McCullough J
    Transfusion; 1993 Jul; 33(7):567-77. PubMed ID: 8333020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a regional bone marrow donor program.
    McCullough J; Scott EP; Halagan N; Strand RA; McGlave P
    JAMA; 1988 Jun; 259(22):3286-9. PubMed ID: 3286909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
    Anasetti C; Hansen JA
    Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer program to predict likelihood of finding and HLA-matched donor: methodology, validation, and application.
    Mori M; Graves M; Milford EL; Beatty PG
    Biol Blood Marrow Transplant; 1996 Oct; 2(3):134-44. PubMed ID: 9199756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience.
    Anasetti C; Howe C; Petersdorf EW; Martin PJ; Hansen JA
    Bone Marrow Transplant; 1994 Jun; 13(6):693-5. PubMed ID: 7920294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The U.S. National Marrow Donor Program.
    Perkins HA; Hansen JA
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):30-4. PubMed ID: 8311171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marrow transplants from unrelated donors.
    Hansen JA; Anasetti C; Petersdorf E; Clift RA; Martin PJ
    Transplant Proc; 1994 Jun; 26(3):1710-2. PubMed ID: 8030096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I and II antigen phenotypes of North American Indians from Minnesota: implications for marrow transplants using unrelated donors.
    Stroncek DF; Strand RD; Noreen HJ; Kline WE; McGlave PB; Bartsch GE; McCullough J
    Transfusion; 1990; 30(6):521-7. PubMed ID: 2378024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to recruit plateletpheresis donors from a registry of HLA-typed, unrelated, bone marrow donors.
    Bolgiano DC; Smith S; Slichter SJ
    Transfusion; 1993 Aug; 33(8):675-8. PubMed ID: 8342236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Marrow Donor Program: how it works, accomplishments to date.
    McCullough J; Hansen J; Perkins H; Stroncek D; Bartsch G
    Oncology (Williston Park); 1989 Feb; 3(2):63-8, 72; discussion 72-4. PubMed ID: 2701411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.
    Tiercy JM; Stadelmann S; Chapuis B; Gratwohl A; Schanz U; Seger RA; Faveri GN; Kern M; Morell A; Schwabe R; Schneider P
    Bone Marrow Transplant; 2003 Sep; 32(6):623-7. PubMed ID: 12953136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.
    Kernan NA; Bartsch G; Ash RC; Beatty PG; Champlin R; Filipovich A; Gajewski J; Hansen JA; Henslee-Downey J; McCullough J
    N Engl J Med; 1993 Mar; 328(9):593-602. PubMed ID: 8429851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Size Estimation of HLA -Ⅰ class Typed Platelet Apheresis Donor Bank].
    Xue M; Pan QQ; Fan S; Wang XY; Zhao F; Liu TX; Shi LL; Ma L; Sheng J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):266-271. PubMed ID: 30738481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic monitoring of bone marrow transplantation. Experience with 16 cases].
    Májský A; Soucek J; Herzog P; Korínková P; Prazák J
    Vnitr Lek; 1990 Apr; 36(4):318-23. PubMed ID: 2141442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Status of data of HLA-typed donors for unrelated bone marrow transplantation in Hannover: organization and results].
    Müller R; Riedel T; Stangel W
    Beitr Infusionsther; 1990; 26():211-3. PubMed ID: 1703833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.